Literature DB >> 24507292

Optimization of HPMC and carbopol concentrations in non-effervescent floating tablet through factorial design.

Sujata Acharya1, Sradhanjali Patra1, Nihar Ranjan Pani2.   

Abstract

This study was to optimize HPMC K4M and carbopol 934 concentration in the development of non-effervescent floating tablets (NEFTs) of glipizide as model drug using 3(2) factorial design. The time required for releasing drug of 50% and 80% and similarity factor were the target responses. HPMC K4M and carbopol 934 concentrations were the variables. The response surface methodology and optimized polynomial equations were used to select the optimal formulation with desired responses. The excipients used in tablets were compatible with glipizide as per the results of isothermal stress testing and DSC study. The drug release of entire NEFTs followed zero order kinetics and non-Fickian diffusion mechanism. Validation of the optimization technique demonstrated the reliability of the model. The optimized formulation containing 124.33 mg HPMC K4M and 25.76 mg carbopol 934 was prepared according to the software determined levels. The stability study of the optimized formulation proved the integrity of the developed formulation.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Glipizide; Non-effervescent floating tablet; Optimization; Response surface methodology

Mesh:

Substances:

Year:  2013        PMID: 24507292     DOI: 10.1016/j.carbpol.2013.11.060

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  2 in total

1.  Thermoreversible nanoethosomal gel for the intranasal delivery of Eletriptan hydrobromide.

Authors:  Santosh Shelke; Sadhana Shahi; Kiran Jadhav; Dinesh Dhamecha; Roshan Tiwari; Hemlata Patil
Journal:  J Mater Sci Mater Med       Date:  2016-04-18       Impact factor: 3.896

2.  Effects of Formulation and Process Variables on Gastroretentive Floating Tablets with A High-Dose Soluble Drug and Experimental Design Approach.

Authors:  Prakash Thapa; Seong Hoon Jeong
Journal:  Pharmaceutics       Date:  2018-09-17       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.